- Home
- IBTA vs AMLX Comparison
IBTA vs AMLX Comparison
Compare IBTA & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBTA
- AMLX
- Stock Information
- Founded
- IBTA 2011
- AMLX 2014
- Country
- IBTA United States
- AMLX United States
- Employees
- IBTA N/A
- AMLX N/A
- Industry
- IBTA
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- IBTA
- AMLX Health Care
- Exchange
- IBTA Nasdaq
- AMLX Nasdaq
- Market Cap
- IBTA 892.4M
- AMLX 749.9M
- IPO Year
- IBTA 2024
- AMLX 2022
- Fundamental
- Price
- IBTA $27.00
- AMLX $11.67
- Analyst Decision
- IBTA Hold
- AMLX Strong Buy
- Analyst Count
- IBTA 10
- AMLX 7
- Target Price
- IBTA $44.33
- AMLX $12.29
- AVG Volume (30 Days)
- IBTA 835.0K
- AMLX 1.8M
- Earning Date
- IBTA 08-13-2025
- AMLX 11-06-2025
- Dividend Yield
- IBTA N/A
- AMLX N/A
- EPS Growth
- IBTA 2512.20
- AMLX N/A
- EPS
- IBTA 2.84
- AMLX N/A
- Revenue
- IBTA $367,604,000.00
- AMLX N/A
- Revenue This Year
- IBTA N/A
- AMLX N/A
- Revenue Next Year
- IBTA $7.41
- AMLX N/A
- P/E Ratio
- IBTA $9.66
- AMLX N/A
- Revenue Growth
- IBTA 3.49
- AMLX N/A
- 52 Week Low
- IBTA $22.50
- AMLX $2.37
- 52 Week High
- IBTA $79.80
- AMLX $12.25
- Technical
- Relative Strength Index (RSI)
- IBTA 43.01
- AMLX 76.78
- Support Level
- IBTA $25.59
- AMLX $9.15
- Resistance Level
- IBTA $27.51
- AMLX $12.25
- Average True Range (ATR)
- IBTA 1.18
- AMLX 0.57
- MACD
- IBTA 0.48
- AMLX 0.22
- Stochastic Oscillator
- IBTA 50.41
- AMLX 84.66
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.